Key result
Cardiac MRI provided additional diagnostic value beyond echocardiography by detecting more severe ventricular dysfunction in 36% of patients, as well as myocardial edema and fibrosis.
Why the study?
Does cardiac MRI provide added diagnostic value and impact clinical management compared to echocardiography in pediatric patients with rheumatologic disorders?
Observational (n=11)
No
Does cardiac MRI provide added diagnostic value and impact clinical management compared to echocardiography in pediatric patients with rheumatologic disorders?
Answers are grounded in this paper and cite their sources.
Cardiac MRI provides additional diagnostic value over echocardiography in pediatric rheumatologic disorders by detecting myocardial edema and fibrosis, which can directly influence immunotherapy management.
Background Systemic Lupus Erythematosus (SLE), Systemic Scleroderma (SSc), and Mixed Connective Tissue Disease (MCTD) are three common rheumatologic conditions with systemic, multi-organ pathologies. Cardiac presentations of these conditions are known to occur, but optimal surveillance strategy for cardiac complications is not well defined. Echocardiography is the most widely utilized modality for assessing cardiac function in patients with concerns for cardiac symptoms. Cardiac MRI may offer additional insights into myocardial edema and fibrosis. However, data on its utility in paediatric patients with rheumatologic disorders remain limited. Purpose This study aimed to elucidate the added value of cardiac MRI in paediatric patients with SLE, SSc and MCTD by comparing its findings to echocardiography and assessing its potential impact on clinical management. Methods We conducted a retrospective study of paediatric patients with SLE, SSc and MCTD who received care at Texas Children’s Hospital from 2014 to 2022. Inclusion criteria encompassed all patients who underwent both cardiac MRIs and echocardiogram within three months. Baseline demographic characteristics were recorded and right and left ventricular function were assessed by both modalities. Evidence of myocardial edema and scar/fibrosis on MRI was documented. Chart review was performed to evaluate changes in management following cardiac MRI. Results A total of 11 patients met inclusion criteria with a median age of 16 years old and at the time of cardiac MRIs and median disease duration of 1.5 years. Ten were female. Diagnose included SLE (4 patients), SSc (4 patients), SLE/SSc overlap (1 patient), and MCTD (2 patients). Echocardiography identified abnormal ventricular function in 5/11 (45%) patients, all of whom had findings confirmed by cardiac MRIs. In addition, cardiac MRIs detected more severe ventricular dysfunction in 4 patients (36%), myocardial edema in 2, and fibrosis in 2 (Table 1, Figure 1). All three patients with edema and/or fibrosis noted on cardiac MRI underwent escalation of immunotherapy, suggesting a clinical impact of these findings. Conclusion Cardiac MRI in paediatric patients with SLE, SSc and MCTD provided additional insights beyond echocardiography, identified more severe ventricular dysfunction and detecting myocardial edema and fibrosis, which influenced treatment decision. These findings highlight the need for larger multicenter studies of cardiac MRI to better characterize cardiac involvement in paediatric rheumatologic disorders.
No takes yet. Share an insight, caveat, or question.
Kannan et al. (2025) conducted an observational in Paediatric rheumatologic disorders (SLE, SSc, MCTD) (n=11). Cardiac MRI vs. Echocardiography was evaluated on Detection of abnormal ventricular function, myocardial edema, and fibrosis. Cardiac MRI provided additional diagnostic value beyond echocardiography by detecting more severe ventricular dysfunction in 36% of patients, as well as myocardial edema and fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: